برای نمایش بهتر وب سایت از ورژن جدید مرورگر فایرفاکس یا گوگل کروم استفاده نمایید.

دانلود ورژن جدید فایرفاکس دانلود ورژن جدید کروم

Center introduction

The Cardiology Research Center of Tabriz University of Medical Sciences has started its activities in 2007 and has expanded its research activities with a new organization and more coherent organization under the supervision of the research deputy of Tabriz University of Medical Sciences; 22 was able to obtain a consensual agreement, and on the date of 9/29/98, he had a definitive agreement. Cardiovascular diseases and mortality due to them are one of the most important problems and problems of public health in today's societies and are considered the first cause of death in East Azarbaijan province. Therefore, the use of academic forces in recognizing native and regional diseases and the implementation of research projects at provincial and national level in order to prevent and provide appropriate strategies for diagnosis and treatment is very important. Considering the role of research in developing and focusing community health in sustainable development, the Cardiology Research Center will try its best in the next few years to prevent cardiovascular diseases, especially cardiac coronary atherosclerosis, the use of stem cells in treatment and The application of genetic knowledge will focus on the diagnosis and treatment of cardiovascular diseases. Therefore, the Cardiology Research Center of Tabriz University of Medical Sciences will work as the main focus of cardiovascular research in order to fully understand the risk factors for cardiovascular diseases, the feasibility of implementing comprehensive prevention plans for this disease. Provides illnesses for all segments of society. The Cardiovascular Research Center, in collaboration with all faculty members of the Department of Cardiology, utilizes the expertise and knowledge of basic science (genetics, biochemistry, cell biology, pharmacy, immunology, etc.) and doctors in other specialties, evaluating and The monitoring of services provided to patients will introduce new ways of treatment (stem cells) and new diagnostic methods (genetics) into the system of services and treatment of cardiovascular diseases in the provinces and the country.